Tandem Diabetes Care TNDM Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.03B+4.5% | $1.01B+7.9% | $1.01B+17.9% | $1B+25.8% | $982.95M+27.7% | ||
| $463.14M-1.4% | $468.72M+4.0% | $470.99M+9.8% | $475.35M+17.2% | $469.64M+20.3% | ||
| $564.4M+10.0% | $546.01M+11.5% | $536.01M+26.0% | $526.37M+34.8% | $513.31M+35.3% | ||
| 54.9%+2.7pp | 53.8%+1.7pp | 53.2%+3.4pp | 52.5%+3.5pp | 52.2%+2.9pp | ||
| $188.93M-6.9% | $193.11M-2.9% | $199.25M+5.3% | $201.64M+11.9% | $202.85M+16.7% | ||
| $439.32M+6.2% | $444.99M+14.2% | $437.73M+18.4% | $428.93M+22.8% | $413.57M+17.2% | ||
| $648.21M-6.3% | $733.27M+24.6% | $732.14M+31.0% | $725.73M+37.0% | $691.64M+31.4% | ||
| $648.21M-6.3% | $733.27M+24.6% | $732.14M+31.0% | $725.73M+37.0% | $691.64M+31.4% | ||
| -$83.81M+53.0% | -$187.26M-88.9% | -$196.13M-46.8% | -$199.36M-43.4% | -$178.33M-21.2% | ||
| -8.2%+10.0pp | -18.5%-7.9pp | -19.5%-3.8pp | -19.9%-2.4pp | -18.1%+1.0pp | ||
| $8.25M+11.8% | $7.91M+6.6% | $7.69M+4.5% | $7.49M-27.5% | $7.38M-27.3% | ||
| -$14.25M-466% | -$13.02M-279% | -$8.81M-185% | -$3.05M-139% | $3.9M-64.2% | ||
| -$14.52M-159% | -$14.19M-591% | -$11.69M— | -$8.97M— | -$5.6M— | ||
| -$102.74M+41.1% | -$204.95M-123% | -$204.95M-66.4% | -$202.43M-54.2% | -$174.45M-28.1% | ||
| -$3.51M— | $4.44M— | —— | —— | —— | ||
| -$94.55M+48.6% | -$204.71M-113% | -$203.37M-60.4% | -$205.45M-50.5% | -$183.87M-30.0% | ||
| -9.2%+9.5pp | -20.2%-10.0pp | -20.2%-5.4pp | -20.5%-3.4pp | -18.7%-0.3pp | ||
| -$1.40+49.6% | -$3.07-110% | -$3.05-58.0% | -$3.09-47.8% | -$2.78-28.1% | ||
| -$1.40+49.6% | -$3.07-110% | -$3.05-58.0% | -$3.09-47.8% | -$2.78-28.1% | ||
| 271.1M+3.0% | 269.1M+2.7% | 267.3M+2.3% | 265.1M+1.7% | 263.1M+0.9% | ||
| 271.1M+3.1% | 269.1M+2.8% | 267M+2.2% | 264.9M+1.6% | 262.9M+0.9% | ||
| -$89.58M+51.0% | -$197.17M-98.5% | -$202.07M-67.4% | -$200.45M-46.8% | -$182.86M-28.5% | ||
| $8.52M-49.5% | $9.09M-49.5% | $10.58M-44.9% | $13.42M-31.4% | $16.87M-24.9% | ||
| -$884K-163% | $566K+282% | -$1.93M-163% | $1.77M+3,930% | $1.41M0.0% | ||
| $1.39M— | -$312K— | -$78K— | -$612K— | $0— | ||
| -$14.25M-466% | -$13.02M-279% | -$8.81M-185% | -$3.05M-139% | $3.9M-64.2% | ||
| $0-100% | $75.22M— | $75.22M— | $75.22M— | $75.22M— | ||
| $188.93M-6.9% | $193.11M-2.9% | $199.25M+5.3% | $201.64M+11.9% | $202.85M+16.7% | ||
| $1.03B+4.5% | $1.01B+7.9% | $1.01B+17.9% | $1B+25.8% | $982.95M+27.7% | ||
| -$83.81M+53.0% | -$187.26M-88.9% | -$196.13M-46.8% | -$199.36M-43.4% | -$178.33M-21.2% | ||
| -$65.95M+59.1% | -$169.59M-106% | -$178.72M-52.5% | -$182.23M-48.3% | -$161.45M-23.5% | ||
| -$65.95M+59.1% | -$169.59M-106% | -$178.72M-52.5% | -$182.23M-48.3% | -$161.45M-23.5% | ||
| -6.4%+10.0pp | -16.7%-7.9pp | -17.7%-4.0pp | -18.2%-2.8pp | -16.4%+0.6pp | ||
| -$83.81M+53.0% | -$187.26M-88.9% | -$196.13M-46.8% | -$199.36M-43.4% | -$178.33M-21.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Tandem Diabetes Care's revenue?
- Tandem Diabetes Care (TNDM) generated $1.0B in revenue over the trailing twelve months, up 4.5% year over year.
- Is Tandem Diabetes Care profitable?
- Tandem Diabetes Care is not currently profitable: it reported a net loss of $94.5M over the trailing twelve months, a -9.2% net margin.
- What are Tandem Diabetes Care's profit margins?
- Gross margin is 54.9% and operating margin is -8.2%, with a -9.2% net margin.
- What is Tandem Diabetes Care's earnings per share?
- Tandem Diabetes Care's diluted EPS over the trailing twelve months is $-1.40.
- Where does Tandem Diabetes Care's income statement data come from?
- Every line is extracted from Tandem Diabetes Care's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
